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Abstract
·AIM: To study the contribution of tonicity response
element binding protein (TonEBP) in retinal ganglion cell
(RGC) death of diabetic retinopathy (DR).
·METHODS: Diabetes was induced in C57BL/6 mice by
five consecutive intraperitoneal injections of 55 mg/kg
streptozotocin (STZ). Control mice received vehicle
(phosphate -buffered saline). All mice were killed 2mo
after injections, and the extent of cell death and the
protein expression levels of TonEBP and aldose
reductase (AR) were examined.
·RESULTS: The TonEBP and AR protein levels and the
death of RGC were significantly increased in the retinas
of diabetic mice compared with controls 2mo after the
induction of diabetes. Terminal deoxynucleotidyl
transferase (TdT) -mediated dUTP nick end labeling
(TUNEL) -positive signals co -localized with TonEBP
immunoreactive RGC. These changes were increased in
the diabetic retinas compared with controls.
·CONCLUSION: The present data show that AR and
TonEBP are upregulated in the DR and TonEBP may
contribute to apoptosis of RGC in the DR.
·KEYWORDS: aldose reductase; diabetes; tonicity response
element binding protein; retinopathy
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INTRODUCTION
D iabetic retinopathy (DR), a vascular disorder affectingmicrovasculature of the retina, is a leading cause of
adult blindness and is the most common complication of
diabetes [1]. But, retinal neurodegeneration, such as retinal
ganglion cell (RGC) death and glial activation, is already
present before any microvascular abnormalities are detected
in ophthalmoscopic examinations [2]. Neural apoptosis is a
feature of DR, and all neuronal cell types in the retina seem
to be susceptible to hyperglycemia-induced apoptosis [3]. But
the mechanism of the regulators in the apoptotic pathway in
DR is still uncertain. Many biochemical pathways associated
with hyperglycemia have been implicated in the development
of diabetic complications including DR. These include
glucose autoxidation, polyol pathway, prostanoid synthesis,
protein glycation, protein kinase C activation, and
hexosamine pathway [4]. And, increased polyol pathway
activity has been linked to abnormalities such as increased
osmotic and oxidative stress factors that have been cited as
promoters of diabetic microvascular diseases [4]. Aldose
reductase (AR), a rate-limiting enzyme of the polyol
pathway, plays important roles in the pathogenesis of
diabetic complications [5]. AR is tightly regulated by
intracellular osmolality at the transcription level [6]. This is
mediated through the osmotic response elements (ORE)
located in the 5' flanking sequences of the AR gene[7].
Tonicity response element binding protein (TonEBP) is a
widely expressed transcription factor whose activity is
regulated by extracellular tonicity and plays a key role in
osmoprotection. Under hypertonic conditions, there is an
increase of TonEBP levels in the nucleus [8]. Studies have
shown that the expression of AR is upregulated by the
TonEBP under high-glucose conditions in diabetic
microvascular complication, especially, diabetic nephropathy[9].
But, until recently, few reports have evaluated the increase of
TonEBP expression and the relationship between AR and
TonEBP in DR.
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In this study, we investigated retinal expression of TonEBP
and whether TonEBP contributes to the ganglion cell death
in the diabetic retinas.
MATERIALS AND METHODS
Materials Male C57BL/6 mice (KOATEC, Pyeongtaek,
Korea) were used in this study. All mice were maintained on
a standard rodent diet and water ad libitum. All animal
procedures for this study were in adherence to the ARVO
statement for the Use of Animals in Ophthalmic and Vision
Research, and were kept in strict accordance with the
Institutional Animal Care and Use Committee of
Gyeongsang National University.
For induction of diabetes, mice were injected
intraperitoneally with 55 mg/kg streptozotocin (STZ; Sigma,
St. Louis, MO, USA) dissolved in 50 mmol/L sodium citrate
(pH 4.5), once a day for 5 consecutive days, and control
mice received buffer. All mice were killed 2mo after
injections. Blood samples were obtained by tail puncture
after 2h fasting, and the blood glucose levels were measured
using a glucometer (Precision, UK). Diabetes was confirmed
by blood glucose levels >13.9 mmol/L, 1wk after the fifth
injection of STZ. Body weights and blood glucose levels in
mice were recorded every week. This study was conducted
in accordance with the Declaration of Helsinki, and was
consistent with good clinical practice guidelines, and was
approved by all institutional review boards.
Methods
Western blot analysis Protein extraction and Western blot
analysis were performed as described previously [10]. To
determine the levels of TonEBP and AR protein expressed,
total proteins were extracted from four different retinas per
each group and we individually performed Western blot
analyses on four independent retinal extracts for each group.
Total proteins (30 滋g) from retinas of each group of mice
was subjected to 10% SDS-PAGE and then transferred to a
nitrocellulose membrane. The blots were incubated in
primary antibody against AR (Abcam 62795, rabbit
polyclonal antibody) and TonEBP (from Dr. Kwon HM at
UNIST, rabbit polyclonal antibody, UNIST, Korea) and in
secondary antibody, HRP-conjugated anti-rabbit IgG
(Rockford, IL, USA). The target proteins were visualized
using an enhanced chemiluminescent kit (Pierce). Each blot
was reprobed with alpha-tubulin or beta-actin to control for
differences in loading. Data are representative of four
independent experiments.
Measurement of changes in inner retinal thickness To
assess inner retinal thickness, the sections were stained with
hematoxylin and eosin (H & E). Then, inner retinal thickness
was measured as the length from the ganglion cell layer
(GCL) to the tip of the inner nuclear layer (INL). Analysis of
the inner retinal thickness in diabetic and control retinas was
performed in four random fields of different retinas from
each group.
Immunohistochemical and TUNEL staining Two months
after injection of streptozotocin or buffer, 12 滋m frozen
retinal sections were prepared as described previously[11]. The
isolated retinas were immersed in 4% PFA for 6h, washed in
phosphate-buffered saline (PBS), cryoprotected in 30%
sucrose overnight at 4℃ , frozen with the optimal cutting
temperature (O.C.T.) compound (Sakura, Tokyo, Japan) in
liquid nitrogen and then cryosectioned at a thickness of
12 滋m using a cryostat (Leica 8400E; Leica, Tokyo, Japan).
After blocking with serum, the sections were incubated in
primary antibody against AR and TonEBP and in secondary
antibody, Alexa 488 goat anti-rabbit IgG (Molecular Probes).
The sections were then counterstained with 4',6-diamidino-2-
phenylindole (DAPI) and mounted in ProLong Gold antifade
reagent (Invitrogen). The number of immunostained RGC
cells was counted in the GCL (within 100 滋m) in three
different fields from 5-6 different retinas for each group.
To detect cell death, we used terminal deoxynucleodityl
transferase (TdT)-mediated dUTP nick-end labeling (TUNEL)
assay kits with TMR red ( Cell Death Detection kits,
Roche, Germany). Cell death was analyzed according to the
manufacturer's directions. To confirm whether the TUNEL-
positive cells are RGCs and TonEBP-immunopositive cells,
we sequencially performed immunofluorescent staining as
described previously for NeuN (Chemicon, mouse monoclonal
antibody, Germany), a ganglion cell marker, and TonEBP
with TUNEL assay according to the manufacturer's
directions on the same cryosections. The total numbers of
TUNEL-positive RGCs that colocalized with TonEBP were
counted in the GCL (within 100 滋m) in three different fields
from 5-6 different retinas for each group.
Image capture and analysis All retinal images were
captured at a diatance of approximately 0.8-1.0 mm from the
optic nerve head using a disk scanning confocal microscope
(Olympus, JP IX2-DSU, Germany). The excitation source
was a 490 nm and 590 nm lasers and all images were taken
under the same experimental conditions to minimize
variations in fluorescence intensity. Quantitative analysis was
performed using the Metamorph Image Analysis software
(Molecular Devices) and bar graphs were constructed using
GraphPad Prism 5. All data are representative of three
independent experiments.
RESULTS
Protein levels of AR and TonEBP were significantly
increased in diabetic retinas compared to control retinas
(Figure 1A, 1B). Increased level of AR and TonEBP were
confirmed by immunostaining in control and diabetic retinas.
TonEBP and AR immunoreactivities were increased in
diabetic retina compared to control retina, and these were
observed especially in the GCL and INL (Figure 2).
Moreover, immunofluorescence study showed retinal
TonEBP and AR immunoreactivities were dramatically
increased and colocalized in diabetic retinas compared to
controls, and the colocalization of TonEBP with AR
immunoreactivity was mostly observed in GCL and INL
(Figure 3). To demonstrate neurodegeneration in the DR, we
examinined the changes of inner retinal thickness and the
expression of active caspase-3. In H & E staining, there was
showed a significant decrease in the inner retinal thickness of
Tonicity response element binding protein and diabetic retinopathy
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Figure 1 Expression of TonEBP and AR in the diabetic retina A: TonEBP and AR protein levels were measured by Western blot
analysis in the control and diabetic retina; B: Note the increased levels of AR and TonEBP protein in diabetic retinas compared to control
retinas.
diabetic mice compared with those of controls (Figure 4). No
diabetes-induced changes were observed in the thickness of
the outer retinal regions (data not shown here). And protein
levels of active caspase-3 were highly increased in the retinas
of diabetic mice compared with controls (Figure 4C, 4D).
To confirm the death of RGCs, triple immunofluorescent
staining of TonEBP (green) and NeuN (violet), the GC
marker, with TUNEL (red) staining was performed on retinal
sections from control and diabetic mice. The total number of
TUNEL-positive RGCs (white arrow, Figure 5A) which
were colocalized with TonEBP significantly increased in the
diabetic mice compared with controls (Figure 5B).
DISCUSSION
In the present study, we firstly found that increased
expression of TonEBP in the DR, especially in the GCL.
Moreover, TonEBP colocalized with AR and TUNEL signals
in diabetic retinas. These results suggest that TonEBP may
contribute to apoptosis of retinal neurons in the DR AR
pathway.
Several clinical studies suggest that neuronal changes occur
prior to clinically detectable microvascular complications.
And, Studies have suggested that retinal neurodegeneration is
a critical component of DR, which is typically characterized
by a reduced number of RGCs and a decreased retinal
thickness. Barber [12] reported a 22% and 14% decrease
in the thickness of the inner plexiform layer (IPL) and INL
of retinal from STZ-induced diabetic rats. Oshitari [13]
showed the number of apoptotic RGCs of diabetic retinas
was significantly increased compared to that in control
retinas. Consistently with previous studies, our result showed
significantly decrease in inner retinal thickness and a
prominent increase in apoptotic RGCs in the retinas of
diabetic mice.
The mechanism of apoptotic processes in RGCs are unclear
Figure 2 Immunohistochemical staining in the diabetic retina. Note the increased retinal TonEBP and AR immunoreactivities in
diabetic mice compared to controls, and these were observed especially in GCL and INL GCL: Ganglion cell layer; IPL: Inner
plexiform layer; INL: Inner nuclear layer; OPL: Outer plexiform layer; ONL: Outer nuclear layer; OS: Outer segment; AR: Aldose
reductase. Scale bar, 50 滋m. White arrow head: Increased retinal TonEBP; Black arrow: Increased retinal AR.
937
Figure 3 Colocalization of TonEBP and AR expression in the retinas of diabetic mice. Note that there was a dramatic increase in
TonEBP and AR expression in GCL of diabetic retina and their colocalization was shown in the merged image GCL: Ganglion cell
layer; IPL: Inner plexiform layer; INL: Inner nuclear layer; OPL: Outer plexiform layer; ONL: Outer nuclear layer; OS: Outer segment; AR:
Aldose reductase. Scale bar, 50 滋m. White arrow head: Increased in TonEBP, White arrow: Increased in AR, Bold arrow: GCL of diabetic
retina and their colocalization.
Figure 4 Changes of inner retinal thickness and Western blot analysis of active caspase-3 in the retinas of diabetic mice A, B: In
H & E staining, diabetic mice showed a significant decrease in the inner retinal thickness, from the GCL to the tip of the INL, compared
with those of controls; C, D: In Western blot analysis of active caspase-3 to confirm cell death, protein levels were highly increased in the
retinas of diabetic mice compared with controls. GCL: Ganglion cell layer; IPL: Inner plexiform layer; INL: Inner nuclear layer; OPL: Outer
plexiform layer; ONL: Outer nuclear layer. Scale bar, 50 滋m.
in DR. Hyperglycemia is one of the important risk factors
and causing increasing metabolic flux through several
biochemical pathways linked to abnormalities such as
increased osmotic and oxidative stress factors, protmoters of
DR [4,14]. Oshitari [13] reported that increased cellular
apoptosis may be associated with Bax overexpression, which
may be responsible for neuronal cell loss in the GCL of
diabetic rats. Kim [15] suggested Ca2+/calmodulin-
dependent protein kinase II (CaMKII) involved in the cell
death pathway of RGCs in the STZ-induced diabetic retinas.
In our study, we found that the total number of
TUNEL-positive RGCs which were colocalized with
TonEBP significantly increased in the diabetic mice
compared with controls. Consequently, these results suggest
Tonicity response element binding protein and diabetic retinopathy
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Figure 5 Triple immunofluorescent staining of TonEBP, TUNEL, and NeuN in retinas of mice 2mo after induction of diabetes
compared with controls A: Triple immunofluorescent staining of TonEBP (green) and NeuN (violet) with TUNEL (red) showed increased
expression of TonEBP colocalized with TUNEL-positive RGCs in diabetic mice (white arrow); B: The total number of TUNEL-positive
RGCs which were colocalized with TonEBP significantly increased in the diabetic mice compared with controls. GCL: Ganglion cell layer;
IPL: Inner plexiform layer; INL: Inner nuclear layer; OPL: Outer plexiform layer; ONL: Outer nuclear layer; OS: Outer segment. Scale bar,
50 滋m.
that TonEBP might play a role in the apoptosis of retinal
neurons AR pathway during the course of DR.
The AR pathway has been studied in relation to all
complications of diabetes including DR. It is well known the
polyol pathway may lead to early changes in the retinal
vasculature including loss of vascular pericytes and
thickening of the basement membrane. And, pro-oxidant
effects of the polyol pathway and the fact that reactive
oxygen species induced by hyperglycemia beget
inflammation, points to the combination of oxidative stress
and inflammation as the distinct signature of the polyol
pathway on retinal vessel [16,17]. Drel [18] reported the
number of TUNEL-positive cell in flat mounted retinas was
increased in diabetic rats compared with the control group,
and this increase was partially corrected by AR inhibitor
(fidarestat). Also, some investigators suggested that neural
apoptosis in the diabetic retina was mediated by increased
activity of the AR pathway and an inhibitor of AR (Sorbinil)
prevented this abnormality [19]. Taken together, AR pathway
may play a role in the neurodegeneration as well as vascular
abnormalities during the development of DR.
The mechanism that initiate and promote neurodegeneration
by upregulation of TonEBP in the DR remains unclear.
TonEBP was initially known for its role in the hypertonic
inner medulla of the kidney for controlling a genetic program
to keep the cellular homeostasis [20]. Recently, many studies
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suggest that TonEBP might play diverse roles. Some reports
suggested that TonEBP contributes to the pathogenesis of
diabetic complications, especially diabetic nephropathy.
Especially, TonEBP binds to the tonicity-reponsive enhancer
element in the promoters of AR genes [9]. So, TonEBP
increases the AR enzyme activity which is associated with
abnormalities in osmotic and oxidative stress factors that
have been cited as promoters of diabetic complications, such
as neurodegeneration[9,21]. Also, since increased activity of the
AR pathway is an important pathogenic factor in diabetic
complications and several inhibitors of AR have been
developed, studies about transcriptional factor that control
AR expression, like TonEBP, may provide insight into the
mechanisms underlying initiation or progression of DR.
To our knowledge, this is the first experimental investigation
suggested that TonEBP contributes to apoptosis of RGC in
the DR. However, this experiment was pilot study. Further
studies are needed to more precisely define the
pathophysiological role of TonEBP and its downstream
target in DR. And, in the present study, TonEBP expression
significantly increased in INL and ONL of the diabetic
retinas as well as GCL (Figures 2, 3). So, future studies
should also include and studies to investigate
whether TonEBP contributes to the microvasculopathy or
apoptosis of other neuronal cells and pericytes.
In conclusion, we confirmed that high glucose increased
expression of AR and TonEBP in the streptozotocin-induced
DR, especially in the GCL. Also, TonEBP-immunopositive
RGCs colocalized with TUNEL signals in DR. These results
suggest that increased expression of TonEBP may contribute
to the apoptosis of retinal neurons in DR.
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